<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>UNLABELLED: <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> is the most serious sequela of the <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> being an obligate precancer with a high index of the <z:e sem="disease" ids="C0007621" disease_type="Neoplastic Process" abbrv="">neoplastic transformation</z:e> as to an <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> esophagus </plain></SENT>
<SENT sid="1" pm="."><plain>THE PURPOSE OF THE PAPER: To reveal the extent of the susceptibility to <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> of the <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo>-patients and to determine high-risk groups </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIALS AND METHODS: Our paper has shown the examination results of the 55 <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo>-patients (29 women and 26 men at the age of 39 to 62 years old), including 40 <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath>-patients and 15 patients of the <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> + <z:mpath ids='MPATH_589'>dysplasia</z:mpath> of long clinical course given corresponding correcting cure </plain></SENT>
<SENT sid="3" pm="."><plain>In our investigation a DNA-flow cytometry was a method of determining the <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> esophagus risk secondary to the <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> as well as an index of the proliferation and an index of the <z:mp ids='MP_0004024'>aneuploidy</z:mp> were the factors analyzed </plain></SENT>
<SENT sid="4" pm="."><plain>THE RESULTS: 1) As the pathosis histology-progresses from <z:mpath ids='MPATH_160'>metaplasia</z:mpath> to <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> esophagus the increase in the <z:mp ids='MP_0004024'>aneuploidy</z:mp> rate, the proliferation index, and S-cycling state cells portion is observed; 2) the proliferation index is a rather stable factor of the human body susceptibility to <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> and varies only slightly in the course of the cure </plain></SENT>
<SENT sid="5" pm="."><plain>The index of the <z:mp ids='MP_0004024'>aneuploidy</z:mp> is a labile factor that can be subject to decrease down to <z:mpath ids='MPATH_458'>normal</z:mpath> figures given corresponding cure (p &gt; 0.05); 3) the increased <z:mp ids='MP_0004024'>aneuploidy</z:mp> index in the presence of the <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> free of esophagus <z:mpath ids='MPATH_589'>dysplasia</z:mpath> can serve as an objective factor for <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">neoplastic progression</z:e> </plain></SENT>
</text></document>